Negative data cost AbbVie billions of dollars in market value and convinced analysts Bristol Myers had placed a better bet in ...

Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...

Doctors and scientists believe migraine is due to "the result of abnormal brain activity affecting nerve signals, chemicals ...

Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.

Covering Saudi Arabia’s markets, the report includes: It encompasses a robust vendor analysis tailored to assist clients in enhancing their market positioning. Specifically, the report furnishes a ...